top of page

Are you struggling with your surgical robot? Are you finding challenges with your complex medical device? Need external experts to take a look and help you? Team Purple has you covered...

 

Search

Version 4: Ultimate Soft Tissue Surgical Robot Comparison Chart


Version 4 soft tissue comparison table Steve Bell
Version 4 Ultimate soft tissue comparison table


Soft Tissue Surgical Robots – Version 4 is here.


This sheet has had a massive update with a ton of new companies and new information: Remember this is from a combination of public sources combined with guesswork so can have some inaccuracies,


What’s inside?


Key features, capabilities, and company details

Key details on system specifications and more

"My comments" column for sharper insights

Curated and structured for fast analysis and investor-level clarity


What's new? - Release notes


🆕 Version 4 Release Notes – Soft Tissue Surgical Robotics

Headline Numbers

Total robots in V3: 72

Total robots in V4: 79

Net increase: +7 systems


✅ New Companies / Systems Added in V4

Accrea Medical Robotics – AVROS-P (passive)

Agibot – AGIBOT

Artisential – STARK

Edda Technology – IQQA

F-Med – Micro Surgery System

Meril – Mizzo Endo 4000 (re-badged Kang Duo?)

Swan Endosurgical – System TBD

TUODAO – Laparoscopic Robot

(Also noted as “new” in structure: CMR Surgical – Versius / Versius PLUS refresh, plus Titan Medical SPORT and Harbin Sagebot variants now marked explicitly as defunct.)


❌ Removed / Reclassified from V3

CMR Surgical – Versius / Versus PLUS (old naming, updated in V4)

Endolumenal – entry structure changed/renamed

Harbin Sagebot – Kangduo and SR2000 entries replaced by “Kangduo – Now defunct” and SR2000 / SR2000-plus

Titan Medical – SPORT (now carried forward as “SPORT – Now defunct”)


🔑 Critical Changes Between Versions

Status updates: Multiple entries explicitly tagged “Now defunct” in V4 (e.g., Harbin Sagebot, Titan Medical), clarifying market exits.

Naming consistency: CMR’s platform updated to “Versius / Versius PLUS” instead of “Versius / Versus PLUS.”

Expansion of coverage: New companies added in emerging markets (China, India, etc.), plus niche systems (micro-surgery, passive arms).

Clarity: Several rows previously vague (“Endolumenal”) restructured or renamed.


-----


Whether you're a startup founder, investor, surgeon, or strategist—this version is your shortcut to understanding who’s doing what, where, and how fast they’re moving.


If you're serious about surgical robotics, Version 4 is your new cheat code.

Don’t just stay updated—stay ahead.


This is aimed at researchers, buyers, marketing professionals, commercial professionals, and anyone that needs to know specifics of all the systems out there. It will help in contracting, tenders, marketing strategies, R&D strategies, commercial strategies, and more.


All current subscription holder get immediate access as part of the subscription

NOTE: The information is copyright and cannot be used by Market Research companies for commercial reports. Information is digitally watermarked. You are free to download but this is a single user license and you cannot distribute this file by any means. It is an indivdual user licence.




Get access here and note this is NOT the standard blog access it is a special list that requires a 99 Euro annual access fee.



Want to read more?

Subscribe to howtostartupinmedtech.com to keep reading this exclusive post.

Get the Ultimate Medtech Survival Guide now

Copyright & Fair Use Notice

All content on this website is the copyright of Steve Bell S.R.L. and remains the proprietary property of the authors. This site utilizes third-party media in good faith for educational commentary and transformative analysis under Fair Use provisions.

1. Mandatory Notice and Takedown: I respect intellectual property. If you believe any material is used outside of fair use, your sole and exclusive remedy is to contact steve@howtostartupinmedtech.com for immediate removal. I will act promptly on any reasonable request.

2. Prohibition of Automated Enforcement: I explicitly prohibit the use of automated "copyright enforcement" bots (including but not limited to PicRights, Copytrack, Pixsy, AP, or Reuters bots) to scrape this site for speculative invoicing.

3. GDPR & Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site, you (the "Scraper") enter into a binding legal contract with Steve Bell S.R.L. You acknowledge that this site contains my Personally Identifiable Information (PII) and personal likeness. As a result:

You are legally deemed a Data Processor under EU GDPR.

Any automated claim sent to Steve Bell S.R.L. or Steve Bell  must be accompanied by a full Article 15 Disclosure Report detailing exactly how my PII was processed and whether it was transferred outside the EEA.

Failure to provide this report or bypassing my technical blocks will be reported to the Italian Data Protection Authority (Garante per la protezione dei dati personali) as a breach of privacy law.

Anti-Scraping & Automated Enforcement Clause

Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site to generate a claim, you (the Scraper) explicitly enter into a binding contract with Steve Bell S.R.L. You agree to waive all automated "settlement" fees in favor of the Notice and Takedown protocol above.

Reinforced statement: GDPR & International Data Transfer: This site contains my personal likeness and identifiable data (PII). Any entity scraping this data becomes a Data Processor under EU law. Any automated claim must be accompanied by a full GDPR Article 15 report detailing where my PII is stored and confirming compliance with international data transfer regulations (EEA to non-EEA). Unauthorized processing will be reported to the Garante per la protezione dei dati personali.

Notice to scraping services: Please read the scraping policy 

How to start a medtech company

©2023-2026 by How to Startup in MedTech 

Steve Bell S.R.L. (unipersonale) – Sede legale: Via Nalles 95, 00124 Roma (RM)  Italy

P.IVA / C.F. 18199441009  – REA RM- 1768831  – Cap. Soc. €10.000 i.v. – PEC: stevebellsrl@pec.it

bottom of page